MRC1 and neoplasm: Second, new evidence of “double somatic” variants in the MMR genes resulting in dMMR in the tumor explains approximately 68% of nonmethylated MMR cases without a germline MMR variant [18,22,23,24] which accounts for 33% to 75% of patients with a dMMR CRC with unexplained MMR deficiency.